Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sarin

Showing results (171-180 of 228) with videos related to

Pageof 23
Sort By:
Biochemical Pharmacology|October 15, 1988
Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitroH C Schröder, P S Sarin, M Rottmann, et al.
Lancet (London, England)|November 30, 1985
HTLV-I and HTLV-III antibodies and tropical spastic paraparesisP Rodgers-Johnson, D C Gajdusek, O S Morgan, et al.
Vaccine|September 6, 2001
Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.
Phlebologie|October 1, 1993
[Is duplex echography mandatory in cases of deep venous insufficiency?]D A Shields, S Andaz, S Sarin, et al.
Science (New York, N.Y.)|February 18, 1983
Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.
The American Journal of Clinical Nutrition|July 1, 1974
Intestinal dipeptidases in primary protein malnutritionR S Hazuria, G S Sarin, P N Srivastava, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.
Haematology and Blood Transfusion|January 1, 1983
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cellsP S Sarin, M Popovic, S Z Salahuddin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Biochemical Pharmacology|November 15, 1986
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell cultureC P Schaffner, O J Plescia, D Pontani, et al.
Pageof 23

Showing results (171-180 of 228) with videos related to

Sort By:
Pageof 23
Biochemical Pharmacology|October 15, 1988
Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitroH C Schröder, P S Sarin, M Rottmann, et al.
Lancet (London, England)|November 30, 1985
HTLV-I and HTLV-III antibodies and tropical spastic paraparesisP Rodgers-Johnson, D C Gajdusek, O S Morgan, et al.
Vaccine|September 6, 2001
Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.
Phlebologie|October 1, 1993
[Is duplex echography mandatory in cases of deep venous insufficiency?]D A Shields, S Andaz, S Sarin, et al.
Science (New York, N.Y.)|February 18, 1983
Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.
The American Journal of Clinical Nutrition|July 1, 1974
Intestinal dipeptidases in primary protein malnutritionR S Hazuria, G S Sarin, P N Srivastava, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.
Haematology and Blood Transfusion|January 1, 1983
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cellsP S Sarin, M Popovic, S Z Salahuddin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Biochemical Pharmacology|November 15, 1986
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell cultureC P Schaffner, O J Plescia, D Pontani, et al.
Pageof 23